Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| Selling General And Administration | 23,937 | 50,270 | 8,078 | 44,989 | 15,283 |
| General And Administrative Expense | 21,584 | 50,270 | 6,625 | 42,124 | 12,288 |
| Other Operating Expenses | 17,057 | 34,828 | 22,012 | 28,227 | 25,887 |
| Operating Expense | 40,994 | 85,098 | 30,090 | 73,216 | 41,170 |
| Operating Income | -40,994 | -85,098 | -30,090 | -73,216 | -41,170 |
| EBIT | -40,994 | -85,098 | -30,090 | -73,216 | -41,170 |
| Other Income Expense | -24,453 | -114,884 | -- | -- | -53,737 |
| Special Income Charges | -1,613 | -158,276 | 0.00 | -- | 0.00 |
| Gain On Sale Of Security | -22,840 | 43,392 | -- | -- | -53,737 |
| Pretax Income | -65,447 | -199,982 | -30,090 | -73,216 | -94,907 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -65,447 | -199,982 | -30,090 | -73,216 | -94,907 |
| Net Income From Continuing Operation Net Minority Interest | -65,447 | -199,982 | -30,090 | -73,216 | -94,907 |
| Net Income Including Noncontrolling Interests | -65,447 | -199,982 | -30,090 | -73,216 | -94,907 |
| Net Income Common Stockholders | -65,447 | -199,982 | -30,090 | -73,216 | -94,907 |
| Net Income | -65,447 | -199,982 | -30,090 | -73,216 | -94,907 |
| EBITDA | -40,994 | -85,098 | -30,090 | -73,216 | -41,170 |
| Normalized EBITDA | -16,541 | 29,786 | -30,090 | -73,216 | 12,567 |
| Reconciled Depreciation | -- | -- | -- | -- | -- |
| Basic EPS | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Diluted EPS | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Basic Average Shares | 28.5M | -- | 28.5M | 28.5M | 28.5M |
| Diluted Average Shares | 28.5M | -- | 28.5M | 28.5M | 28.5M |
| Total Unusual Items | -24,453 | -114,884 | 0.00 | -- | -53,737 |
| Total Unusual Items Excluding Goodwill | -24,453 | -114,884 | 0.00 | -- | -53,737 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -40,994 | -85,098 | -30,090 | -73,216 | -41,170 |
| Diluted NI Availto Com Stockholders | -65,447 | -199,982 | -30,090 | -73,216 | -94,907 |
| Impairment Of Capital Assets | 1,613 | 158,276 | 0.00 | -- | 0.00 |
| Net Income Continuous Operations | -65,447 | -199,982 | -30,090 | -73,216 | -94,907 |
| Other Gand A | 6,900 | 9,500 | 5,500 | 41,374 | 9,229 |
| Reconciled Cost Of Revenue | -- | -- | -- | -- | -- |
| Rent And Landing Fees | 1,125 | 1,125 | 1,125 | 750.00 | 3,059 |
| Rent Expense Supplemental | 1,125 | 1,125 | 1,125 | 750.00 | 3,059 |
| Salaries And Wages | 13,559 | 39,645 | 0.00 | -- | 0.00 |
| Selling And Marketing Expense | 2,353 | 0.00 | 1,453 | 2,865 | 2,995 |
| Total Expenses | 40,994 | 85,098 | 30,090 | 73,216 | 41,170 |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 18,544 | 7,310 | 33,647 | 58,219 | 75,700 |
| Cash Cash Equivalents And Short Term Investments | 56,431 | 97,697 | 105,297 | 129,869 | 147,350 |
| Cash Financial | 18,544 | 7,310 | 33,647 | 58,219 | 75,700 |
| Other Short Term Investments | 37,887 | 90,387 | 71,650 | 71,650 | 71,650 |
| Receivables | 1,976 | 7,625 | 5,392 | 4,007 | 2,362 |
| Current Assets | 58,407 | 105,322 | 110,689 | 133,876 | 149,712 |
| Net PPE | 1.9M | 1.9M | 2.0M | 2.1M | 2.1M |
| Total Non Current Assets | 1.9M | 1.9M | 2.0M | 2.1M | 2.1M |
| Total Assets | 1.9M | 2.0M | 2.2M | 2.2M | 2.2M |
| Accounts Payable | 26,263 | 19,161 | 17,626 | 35,723 | 0.00 |
| Payables | 31,263 | 24,161 | 22,626 | 35,723 | 5,000 |
| Payables And Accrued Expenses | 116,263 | 109,161 | 107,626 | 120,723 | 90,000 |
| Current Accrued Expenses | 85,000 | 85,000 | 85,000 | 85,000 | 85,000 |
| Current Liabilities | 119,666 | 112,564 | 111,029 | 129,126 | 93,403 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 119,666 | 112,564 | 111,029 | 129,126 | 93,403 |
| Common Stock | 15.9M | 15.9M | 15.9M | 15.9M | 15.9M |
| Capital Stock | 15.9M | 15.9M | 15.9M | 15.9M | 15.9M |
| Retained Earnings | -15.5M | -15.4M | -15.2M | -15.2M | -15.1M |
| Common Stock Equity | 1.8M | 1.9M | 2.0M | 2.1M | 2.1M |
| Stockholders Equity | 1.8M | 1.9M | 2.0M | 2.1M | 2.1M |
| Total Equity Gross Minority Interest | 1.8M | 1.9M | 2.0M | 2.1M | 2.1M |
| Total Capitalization | 1.8M | 1.9M | 2.0M | 2.1M | 2.1M |
| Net Tangible Assets | 1.8M | 1.9M | 2.0M | 2.1M | 2.1M |
| Tangible Book Value | 1.8M | 1.9M | 2.0M | 2.1M | 2.1M |
| Working Capital | -61,259 | -7,242 | -340.00 | 4,750 | 56,309 |
| Invested Capital | 1.8M | 1.9M | 2.0M | 2.1M | 2.1M |
| Share Issued | 28.5M | 28.5M | 28.5M | 28.5M | 28.5M |
| Ordinary Shares Number | 28.5M | 28.5M | 28.5M | 28.5M | 28.5M |
| Current Deferred Liabilities | -- | -- | -- | 5,000 | -- |
| Current Provisions | 3,403 | 3,403 | 3,403 | 3,403 | 3,403 |
| Dueto Related Parties Current | 5,000 | 5,000 | 5,000 | -- | 5,000 |
| Other Equity Interest | 1.4M | 1.4M | 1.3M | 1.3M | 1.3M |
| Other Receivables | 808.00 | 808.00 | 808.00 | 808.00 | 807.00 |
| Taxes Receivable | 1,168 | 6,817 | 4,584 | 3,199 | 1,555 |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -14,684 | -46,151 | -49,572 | -39,138 | -41,209 |
| Cash Flow From Continuing Operating Activities | -14,684 | -46,151 | -49,572 | -39,138 | -41,209 |
| Depreciation And Amortization | -- | -- | -- | -- | -- |
| Depreciation Amortization Depletion | -- | -- | -- | -- | -- |
| Stock Based Compensation | 13,559 | 39,645 | -- | -- | 0.00 |
| Change In Working Capital | 12,751 | -698.00 | -19,482 | 34,078 | -39.00 |
| Change In Receivables | 5,649 | -2,233 | -1,385 | -1,645 | 562.00 |
| Change In Payables And Accrued Expense | 7,102 | 1,535 | -18,097 | 35,723 | -601.00 |
| Change In Payable | 7,102 | 1,535 | -18,097 | 35,723 | -601.00 |
| Change In Other Current Assets | -- | -- | 0.00 | 0.00 | 0.00 |
| Capital Expenditure | -- | -4,841 | -- | -- | -- |
| Purchase Of PPE | -- | -4,841 | 0.00 | -- | -- |
| Net PPE Purchase And Sale | -- | -4,841 | 0.00 | -- | -- |
| Sale Of Investment | 29,660 | -- | -- | -- | 0.00 |
| Net Investment Purchase And Sale | 29,660 | -- | -- | -- | 0.00 |
| Investing Cash Flow | 25,918 | 19,814 | 25,000 | 21,657 | 22,636 |
| Cash Flow From Continuing Investing Activities | 25,918 | 19,814 | 25,000 | 21,657 | 22,636 |
| Changes In Cash | 11,234 | -26,337 | -24,572 | -17,481 | -18,573 |
| Beginning Cash Position | 7,310 | 33,647 | 58,219 | 75,700 | 94,273 |
| End Cash Position | 18,544 | 7,310 | 33,647 | 58,219 | 75,700 |
| Free Cash Flow | -14,684 | -50,992 | -49,572 | -44,845 | -41,209 |
| Asset Impairment Charge | 1,613 | 158,276 | -- | -- | 0.00 |
| Depreciation | -- | -- | -- | -- | -- |
| Gain Loss On Investment Securities | 15,340 | -- | -- | -- | -- |
| Net Income From Continuing Operations | -65,447 | -199,982 | -30,090 | -73,216 | -94,907 |
| Net Other Investing Changes | -3,742 | 0.00 | 25,000 | 27,364 | 22,636 |
| Operating Gains Losses | 15,340 | -- | -- | -- | -- |
| Unrealized Gain Loss On Investment Securities | 7,500 | -48,737 | 0.00 | 0.00 | 53,737 |